Middle East News Watch
SEE OTHER BRANDS

The latest news from the Middle East

Middle East News Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Watch.

Press releases published on July 28, 2025

Fabrika Coffee Packaging by Eugene Wysota and Helen Trophimova Wins Silver in A' Design Awards

Fabrika Coffee Packaging by Eugene Wysota and Helen Trophimova Wins Silver in A' Design Awards

W Design Bureau's Innovative Packaging Design for Fabrika Coffee Recognized with Prestigious Silver A' Design Award in Packaging Design Category COMO, CO, ITALY, July 28, 2025 /⁨EINPresswire.com⁩/ -- The A' Design Award, one of the world's most …

Winglets Market Size Expected to Reach $4.7 Billion by 2031

Winglets Market Size Expected to Reach $4.7 Billion by 2031

Winglets market was valued at $2.4 billion in 2021, and is estimated to reach $4.7 billion by 2031, growing at a CAGR of 7.4% WILMINGTON, DE, UNITED STATES, July 28, 2025 /⁨EINPresswire.com⁩/ -- By aircraft type, the narrow body aircraft segment dominated …

Aircraft Mounts Market Size Expected to Reach $1.15 Billion by 2030

Aircraft Mounts Market Size Expected to Reach $1.15 Billion by 2030

Aircraft Mounts market was valued at $580.0 million in 2020, and is projected to reach $1,153.5 million by 2030, registering a CAGR of 7.3% WILMINGTON, DE, UNITED STATES, July 28, 2025 /⁨EINPresswire.com⁩/ -- By mount type, the engine mounts segment …

Fulcrum Therapeutics to Present Results from the 12 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease

Fulcrum Therapeutics to Present Results from the 12 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease

CAMBRIDGE, Mass., July 28, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Fulcrum) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare …

Healthy4U Integrates with Apple Health and Major Fitness Trackers, Unlocking a New Era of Deeply Personalized Wellness

Healthy4U Integrates with Apple Health and Major Fitness Trackers, Unlocking a New Era of Deeply Personalized Wellness

Healthy4U now syncs with Apple Health and top trackers, delivering deeper insights and truly personalized health recommendations. TEL AVIV, TEL AVIV, ISRAEL, July 28, 2025 /⁨EINPresswire.com⁩/ -- Healthy4U, an Israeli health-tech startup and the first in …

Target Drone Market Size Expected to Reach $8.55 Billion by 2030

Target Drone Market Size Expected to Reach $8.55 Billion by 2030

Global target drone market was valued at $4.46 billion in 2020, and is projected to reach $8.55 billion by 2030, registering a CAGR of 6.9%. WILMINGTON, DE, UNITED STATES, July 28, 2025 /⁨EINPresswire.com⁩/ -- Rise in spending to procure defense equipment …

Qualigen Therapeutics Announces $4.5 Million Private Placement of Series A-3 Convertible Preferred Stock

Qualigen Therapeutics Announces $4.5 Million Private Placement of Series A-3 Convertible Preferred Stock

Carlsbad, CA, July 28, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ:QLGN) ("Qualigen" or the "Company"), a life sciences company focused on developing platform treatments for adult and pediatric cancers with the potential for orphan drug …

Can-Fite Announces Up To $15.0 Million Public Offering

Can-Fite Announces Up To $15.0 Million Public Offering

$5.0 million upfront with up to an additional $10.0 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants RAMAT GAN, Israel, July 28, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: …

More High-Grade Antimony Intersected

More High-Grade Antimony Intersected

ROUYN-NORANDA, Quebec, July 28, 2025 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang …

Full Alliance Group Reports Second Quarter Preliminary results, Unveils Expansion into High-Growth Men's Wellness Personal Care and Health Virility segment, Association Digital Benefits, and Expands its Contract Manufacturing Markets

Full Alliance Group Reports Second Quarter Preliminary results, Unveils Expansion into High-Growth Men's Wellness Personal Care and Health Virility segment, Association Digital Benefits, and Expands its Contract Manufacturing Markets

TAMPA, Fla., July 28, 2025 (GLOBE NEWSWIRE) -- Full Alliance Group, Inc. (OTC: FAGI) today announced preliminary unaudited revenue results for the second quarter of 2025 and provided an exciting outlook for the remainder of the year, driven by strategic …

Saudia Joins Esports World Cup as Official Airline Partner, Advancing Sports Tourism in the Kingdom

Saudia Joins Esports World Cup as Official Airline Partner, Advancing Sports Tourism in the Kingdom

RIYADH, Saudi Arabia, July 28, 2025 (GLOBE NEWSWIRE) -- Saudia, the national flag carrier of Saudi Arabia, has announced the signing of a partnership with the Esports World Cup Foundation (EWCF), becoming the Official Airline Partner of the tournament. The …

Globex Mining Enterprises Inc. Announces Renewal of Normal Course Issuer Bid

Globex Mining Enterprises Inc. Announces Renewal of Normal Course Issuer Bid

ROUYN-NORANDA, Québec, July 28, 2025 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang …

AIM ImmunoTech Reports Positive Mid-year Safety and Efficacy Data from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer

AIM ImmunoTech Reports Positive Mid-year Safety and Efficacy Data from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer

OCALA, Fla., July 28, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today reported positive data in a mid-year update from the ongoing Phase 2 clinical study evaluating AIM’s drug Ampligen® (rintatolimod) …

Latin Metals Expands Organullo Gold Project, Salta Province, Argentina

Latin Metals Expands Organullo Gold Project, Salta Province, Argentina

VANCOUVER, British Columbia, July 28, 2025 (GLOBE NEWSWIRE) -- Latin Metals Inc. ("Latin Metals" or the "Company") (TSXV: LMS) (OTCQB: LMSQF) is pleased to report that following an application submitted to the mining authorities in Salta Province, the …

Enlivex Reaffirms August 18, 2025 As Target Date For Announcement of Phase II Topline Data

Enlivex Reaffirms August 18, 2025 As Target Date For Announcement of Phase II Topline Data

Nes-Ziona, Israel, July 28, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that all 134 patients in its Phase II stage of its randomized, …

Supernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Sage Therapeutics, Inc. Tender Offer

Supernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Sage Therapeutics, Inc. Tender Offer

ROCKVILLE, Md., July 28, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc., a Delaware corporation (NASDAQ: SUPN) ("Supernus", and the "Company"), today announced that the required waiting period under the Hart-Scott-Rodino Antitrust Improvements Act …

ParaZero Successfully Completes Field Trial of New Configuration of the DefendAir System, Offering a Comprehensive Counter-Drone Solution

ParaZero Successfully Completes Field Trial of New Configuration of the DefendAir System, Offering a Comprehensive Counter-Drone Solution

Kfar Saba, Israel, July 28, 2025 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospa ce defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) …

ProQR Announces Upcoming Presentation at RNA Editing Summit

ProQR Announces Upcoming Presentation at RNA Editing Summit

LEIDEN, Netherlands …

Acumen Pharmaceuticals Presents Studies Showing the Utility of a pTau217 Assay in Screening for a Phase 2 Alzheimer’s Disease Trial and Validates Sabirnetug Oligomer-Selectivity, at the Alzheimer’s Association International Conference (AAIC) 2025

Acumen Pharmaceuticals Presents Studies Showing the Utility of a pTau217 Assay in Screening for a Phase 2 Alzheimer’s Disease Trial and Validates Sabirnetug Oligomer-Selectivity, at the Alzheimer’s Association International Conference (AAIC) 2025

NEWTON, Mass., July 28, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer’s …

UroGen Announces Publication of Phase 3b Study Results Demonstrating the Feasibility of Home Instillation of ZUSDURI™ for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer in Reviews in Urology

UroGen Announces Publication of Phase 3b Study Results Demonstrating the Feasibility of Home Instillation of ZUSDURI™ for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer in Reviews in Urology

PRINCETON, N.J., July 28, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative treatments for urothelial and specialty cancers, today announced the publication in Reviews in …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions